NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/08/2025
Voltar para busca
Dado oficial do USPTO
MERCALIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MERCALIS
ST13
US500000097916626Classe
35, 36, 41, 42, 45
Pedido
97916626
Registro
7892673
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
12/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 41, 42, 45
Data de depósito
02/05/2023
Data de registro
12/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/08/2025
Última transação
12/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
20/09/2023
Primeiro uso no comércio
20/09/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
MORRISVILLE, NC, US
Examinador
STEEL, ALYSSA PALADINO
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MERCALIS INC.
T. I. (pessoa física)
Representantes
Larry L. Coats COATS & BENNETT, PLLC
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 41Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business management and administration of pharmacy reimbursement programs; Managing and administering the distribution of prescription pharmaceutical samples to physicians and patients for pharmaceutical manufacturers; Business management and administration of patient co-pay reimbursement programs on behalf of pharmaceutical manufacturers; Business management and administration of financial assistance programs that provide patients with access to affordable medicinenamely business management and administration of enrollment and reimbursement programs for the purchase of medication and generally facilitating access to medications; Business management and administration of patient support programs for pharmaceutical manufacturers; Business management and administration of patient engagement programs for pharmaceutical manufacturers; Business management and administration of formularypatientpayer policy information for pharmaceuticalmedical devicediagnostic manufacturers; Business management and administration of educational engagements for Health Care Providersbusiness management and administration of efforts to educate healthcare providers on medicationsdisease status and standard of care; Management of the distribution of clinical trial medication and supplies on behalf of pharmaceutical manufacturers; Providing business marketing informationtracking pharmaceutical promotional programs for pharmaceutical manufacturers and evaluating and determining their effectiveness; Data management services in the field of pharmaceutical patient safetycollecting adverse product events datastoring the datareporting collected adverse product events data; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturerspromoting awareness of diseasespharmaceutical brandstreatment affordable options; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturersmarketing services in the nature of promotion of pharmaceutical manufacturers and disease treatment options via social media; Business information servicestracking payer coverage policies and related documentation and providing life sciences clients access to such in order to enhance their market access strategies and patient support programs; Life science business strategy consulting services for assisting clients with commercial assessmentscorporate and portfolio strategynew product planning and commercialization supportpricing and market access insights; Business assistance servicesenrolling patients of pharmaceutical manufacturers into support programs that enable patients to viewtrackmanage the support program wherein the patient support program provides pharmaceutical consumer product informationpayer coverage status updatesproviding business information regarding access to enrollment and reimbursement programs for the purchase of medications; Providing business information and news to the pharmaceutical and life sciences industries on legislative and regulatory developments as it impacts and relates to the pharmaceutical and life sciences industries within the copay or patient affordability space
Classe 36
Payment servicesreimbursement payment processing in the field of pharmaceutical financial assistance programs and loyalty program payment processing services provided on behalf of pharmaceutical manufacturers for the purpose of delivering benefits to patients enrolled in pharmaceutical manufacturer-sponsored financial assistance programs; Pharmacy benefit manager (PBM) accumulator mitigation services and detecting claim activity indicative of a pharmacy benefit manager attempting to abuse the use of co-pay cards by not applying amounts paid by clients towards the patient's deductible or annual out-of-pocket expense; Anti-kickback and risk mitigation services for the pharmaceutical industryantikickback compliance services for assuring that patients who have full or partial federally funded drug coverage are excluded from utilizing co-pay cards
Classe 41
Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturersproviding podcastsseminarsworkshopsvirtual and in-person presentations for educational purposes in the field of diseasespharmaceutical brandsaffordable healthcare options
Classe 42
Quality assurance and quality control patient claim services for monitoring paid claims to patients from insurance or pharmaceutical entities to insure that specific business rules are being correctly applied to patient claims; Pharmacovigilance services for othersscientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical productsassessment of risks presented by certain pharmaceutical products or combinations thereofproduct safety testing and consultation related thereto in the field of pharmaceuticals; Pharmacovigilance services for othersmonitoring the quality of efficacy of pharmaceutical preparations; Providing online non-downloadable software for patient support servicesfor enrolling patients of pharmaceutical manufacturers in support programs that enables the patients to viewtrack and manage the support program wherein the patient support program provides pharmaceutical product and medication educationmedication adherence supportvisibility into medication delivery and case statusclinical support services including injection and product educational trainingaccess to financial assistance programspayer coverage status updatespatient engagement services and reminders and notifications
Classe 45
Pharmacy benefit fraud monitoringinvestigation services related to pharmacy benefit insurance claims
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/08/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
18/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
16/07/2025
IUAF
USE AMENDMENT FILED
03/04/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/04/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/08/2024
PUBO
PUBLISHED FOR OPPOSITION
13/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2024
GNRT
NON-FINAL ACTION E-MAILED
05/07/2024
CNRT
NON-FINAL ACTION WRITTEN
05/07/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/07/2024
DOCK
ASSIGNED TO EXAMINER
09/06/2024
DOCK
ASSIGNED TO EXAMINER
15/05/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
14/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/05/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/05/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/05/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/01/2024
GNRT
NON-FINAL ACTION E-MAILED
29/01/2024
CNRT
NON-FINAL ACTION WRITTEN
29/01/2024
DOCK
ASSIGNED TO EXAMINER
29/01/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/05/2023
NWAP
NEW APPLICATION ENTERED
05/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MERCALIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.